I'm only saying this again, because I like some of you.
The conversion ratio for this merger has already been determined. You guys are going to get around 1.49 shares of nxpl for every share of rxmd you own. Currently, nxpl is at 1.21 per share. If you take 1.21x1.49, you get 1.80. If you are buying rxmd above that price at 1.93, you are losing 13 cents a share on the conversion. You'd be better off just buying nxpl. This is why the bid is around 1.79-1.80 on rxmd. They know it makes sense with the conversion. Of course, this is all assuming the merger goes through, or you aren't trying to do a quick flip.
If the price of nxpl rises, the bid on rxmd should also rise. Still, you need to check the conversion formula, to determine which one makes sense before you buy.
News 
Market Data 
Discover 
